BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hwang S, Lee SG, Lee YJ, Ahn CS, Kim KH, Park KM, Moon KM, Moon DB, Ha TY, Yu ES, Choi GW. Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation. J Gastrointest Surg. 2008;12:718-724. [PMID: 17999122 DOI: 10.1007/s11605-007-0393-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hwang S, Moon D, Ahn C, Kim K, Ha T, Song G, Jung D, Park G, Lee H, Lee Y, Chung Y, Abdulkarim B, Lee S. Risk-Based Long-Term Screening for Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation. Transplantation Proceedings 2013;45:3076-84. [DOI: 10.1016/j.transproceed.2013.08.068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Bello HR, Mahdi ZK, Lui SK, Nandwana SB, Harri PA, Davarpanah AH. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation. J Magn Reson Imaging 2021. [PMID: 33682266 DOI: 10.1002/jmri.27553] [Reference Citation Analysis]
3 Mi B, Wan W, Yu C, You X, Xu Q. Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT. Clin Nucl Med. 2011;36:925-927. [PMID: 21892049 DOI: 10.1097/rlu.0b013e31821c9939] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Eur J Med Genet 2021;64:104313. [PMID: 34418585 DOI: 10.1016/j.ejmg.2021.104313] [Reference Citation Analysis]
5 Mitchell KA. Hepatocellular carcinoma: histologic considerations: pure, mixed, and motley. J Clin Gastroenterol 2013;47 Suppl:S20-6. [PMID: 23632363 DOI: 10.1097/MCG.0b013e318291f237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
6 Zhang C, Feng S, Tu Z, Sun J, Rui T, Zhang X, Huang H, Ling Q, Zheng S. Sarcomatoid hepatocellular carcinoma: From clinical features to cancer genome. Cancer Med 2021. [PMID: 34331411 DOI: 10.1002/cam4.4162] [Reference Citation Analysis]
7 Morisue R, Kojima M, Suzuki T, Nakatsura T, Ojima H, Watanabe R, Sugimoto M, Kobayashi S, Takahashi S, Konishi M, Ishii G, Gotohda N, Fujiwara T, Ochiai A. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses. Int J Cancer 2021;149:546-60. [PMID: 33662146 DOI: 10.1002/ijc.33545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang JP, Yao ZG, Sun YW, Liu XH, Sun FK, Lin CH, Ren FX, Lv BB, Zhang SJ, Wang Y, Meng FY, Zheng SZ, Gong W, Liu J. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4327-4342 [PMID: 32848337 DOI: 10.3748/wjg.v26.i29.4327] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. J Hepatocell Carcinoma 2021;8:1117-27. [PMID: 34522692 DOI: 10.2147/JHC.S325182] [Reference Citation Analysis]
10 Yu Y, Zhong Y, Wang J, Wu D. Sarcomatoid hepatocellular carcinoma (SHC): a case report. World J Surg Oncol. 2017;15:219. [PMID: 29233162 DOI: 10.1186/s12957-017-1286-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
11 Da Ines D, Bailly A, Lannareix V, Petitcolin V, Boldor L, Charpy C, Abergel A, Pezet D, Garcier JM. Hepatocellular carcinoma with sarcomatous change: prompt and fatal intraabdominal recurrence after liver transplantation. Gastroenterol Clin Biol. 2009;33:590-593. [PMID: 19481391 DOI: 10.1016/j.gcb.2009.04.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Chen CY, Hsueh YT, Lan TY, Lin WH, Wu K, Yang RS. Pelvic skeletal metastasis of hepatocellular carcinoma with sarcomatous change: a case report. Diagn Pathol 2010;5:33. [PMID: 20500842 DOI: 10.1186/1746-1596-5-33] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
13 Seok JY, Kim YB. [Sarcomatoid hepatocellular carcinoma]. Korean J Hepatol. 2010;16:89-94. [PMID: 20375648 DOI: 10.3350/kjhep.2010.16.1.89] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
14 Tandan S, Sun K, Gaglio PJ. A rare finding on liver explant. Clin Gastroenterol Hepatol 2014;12:e85-6. [PMID: 24561510 DOI: 10.1016/j.cgh.2014.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Luo C, Xin H, Yin D, Zhao T, Hu Z, Zhou Z, Sun R, Yao N, Sun Q, Fan J, Huang X, Zhou J, Zhou S. Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma. Aging (Albany NY) 2021;13:15126-38. [PMID: 34081621 DOI: 10.18632/aging.203076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology. 2019;69:209-221. [PMID: 30014620 DOI: 10.1002/hep.30162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
17 Lee KB. Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation. Clin Mol Hepatol 2014;20:313-6. [PMID: 25320737 DOI: 10.3350/cmh.2014.20.3.313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Lu J, Xiong XZ, Li FY, Ye H, Lin YX, Zhou RX, Cai YL, Jin YW, Cheng NS. Prognostic Significance of Sarcomatous Change in Patients with Hepatocellular Carcinoma After Surgical Resection. Ann Surg Oncol. 2015;22 Suppl 3:S1048-S1056. [PMID: 26286198 DOI: 10.1245/s10434-015-4818-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gu KW, Kim YK, Min JH, Ha SY, Jeong WK. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY) 2017;42:1424-33. [PMID: 28078380 DOI: 10.1007/s00261-016-1038-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
20 Yang Z, Lv K, Zhao Y, Pan M, Zhang C, Wei S. Sarcomatoid hepatocellular carcinoma mimicking hepatic abscess: A case report. Medicine (Baltimore) 2020;99:e22489. [PMID: 32991488 DOI: 10.1097/MD.0000000000022489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ohya K, Saitoh S, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Kobayashi M, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kinowaki K, Fujii T, Kondo F, Kumada H. Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases. Hepatol Res 2019;49:711-7. [DOI: 10.1111/hepr.13295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Ge D, Luo Z, Mao R, Zhao H, Lv X, Zhao J, Zhou J, Huang Z, Zhang Y, Li Z, Bi X, Cai J. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Adv Ther 2020;37:3185-205. [PMID: 32436026 DOI: 10.1007/s12325-020-01357-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Chen YS, Lim WX, Lin AN, Chen CL, Tsang LL, Yu CY, Hsu HW, Chuang YH, Cheng YF, Ou HY. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Living Donor Liver Transplant. Transplant Proc 2022:S0041-1345(21)00911-8. [PMID: 35022135 DOI: 10.1016/j.transproceed.2021.09.071] [Reference Citation Analysis]
24 Shi D, Ma L, Zhao D, Chang J, Shao C, Qi S, Chen F, Li Y, Wang X, Zhang Y, Zhao J, Li H. Imaging and clinical features of primary hepatic sarcomatous carcinoma. Cancer Imaging. 2018;18:36. [PMID: 30314525 DOI: 10.1186/s40644-018-0171-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
25 Piccirillo M, Granata V, Albino V, Palaia R, Setola SV, Petrillo A, Tatangelo F, Botti G, Foggia M, Izzo F. Can Hepatocellular Carcinoma (HCC) Produce Unconventional Metastases? Four Cases of Extrahepatic HCC. Tumori 2013;99:e19-23. [DOI: 10.1177/030089161309900127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
26 Hwang S, Ahn C, Kim K, Moon D, Ha T, Song G, Jung D, Park G, Yu Y, Park P, Choi Y, Kim K, Lim Y, Lee HC, Yu E, Lee S. Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation. J Gastrointest Surg 2011;15:971-81. [DOI: 10.1007/s11605-011-1467-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
27 Ling LL, Hsu C, Yong C, Elsarawy AM, Chan Y, Wang C, Li W, Lin T, Kuo F, Cheng Y, Lin L, Chen C, Lin C. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study. International Journal of Surgery 2019;69:124-31. [DOI: 10.1016/j.ijsu.2019.07.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 Yoshida N, Midorikawa Y, Kajiwara T, Yoshida N, Nakayama H, Sugitani M, Takayama T. Hepatocellular Carcinoma with Sarcomatoid Change without Anticancer Therapies. Case Rep Gastroenterol 2013;7:169-74. [PMID: 23626518 DOI: 10.1159/000350558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
29 Seo N, Kim MJ, Rhee H. Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system. Eur Radiol 2019;29:3761-71. [PMID: 30859282 DOI: 10.1007/s00330-019-06052-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
30 Orlando G, Lai Q, Lerut J. Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component. Hepatobiliary Pancreat Dis Int 2020;19:184-6. [PMID: 31899134 DOI: 10.1016/j.hbpd.2019.11.010] [Reference Citation Analysis]
31 Lu J, Zhang J, Xiong XZ, Li FY, Ye H, Cheng Y, Zhou RX, Lin YX, Cheng NS. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases. J Cancer Res Clin Oncol. 2014;140:1027-1035. [PMID: 24647927 DOI: 10.1007/s00432-014-1641-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
32 Chang WC, Hsu HH, Chiu SH, Huang WY, Lo CH, Lin HH, Huang PC, Shih YL, Wan YL. Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads. J Hepatocell Carcinoma 2021;8:937-49. [PMID: 34422707 DOI: 10.2147/JHC.S319920] [Reference Citation Analysis]